In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in ...

March 26, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

Cingulate (CING) reported that as of December 31, 2024, the company had approximately $12.2M in cash and cash equivalents, a $12.1M increase ...

Cingulate (NASDAQ:CING – Get Free Report) is expected to release its earnings data before the market opens on Monday, March ...

Being raised by two therapists isn't easy by any means, but it did give me a unique perspective on my neuroscience research.

In a report released today, Boobalan Pachaiyappan from Roth MKM maintained a Buy rating on Cingulate Inc (CING – Research Report), with a price ...

Next time you feel an itch, remember that your brain's vast network of neurons informs it whether it is an itch or pain. A ...

A study from UNLV suggests that Type 2 diabetes impairs the anterior cingulate cortex (ACC), which is linked to reward ...

New research reveals that Type 2 diabetes may impair the brain’s reward and memory processing in ways that mirror early Alzheimer’s disease.

Study reveals how diabetes rewires the brain, affecting memory and reward processing by linking high blood sugar to changes ...